학술논문

Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
Document Type
article
Source
Subject
Clinical Research
Breast Cancer
Cancer
Prevention
Nuclear Medicine & Medical Imaging
Medical and Health Sciences
Language
Abstract
Background The COVID-19 pandemic reduced mammography utilization, potentially delaying breast cancer diagnoses. Purpose To examine breast biopsy recommendations and breast cancers diagnosed before and during the COVID-19 pandemic by mode of detection (screen-detected versus symptomatic) and women's characteristics. Materials and Methods In this secondary analysis of prospectively collected data, monthly breast biopsy recommendations following mammography and/or ultrasound with subsequent biopsy performed were examined from 66 facilities of the Breast Cancer Surveillance Consortium between January 2019 and September 2020. Monthly and cumulative biopsies recommended and performed, and subsequent cancers diagnosed in the pandemic period (March-September 2020) versus the pre-pandemic period were compared using Wald chi-squared tests. Analyses were stratified by mode of detection and race/ethnicity. Results From January 2019 to September 2020, 17,728 biopsies were recommended and performed with 6,009 subsequent cancers diagnosed. From March to September 2020, there were substantially fewer breast biopsy recommendations with cancer diagnoses compared to 2019 (1,650 in 2020 versus 2,171 in 2019, or 24% fewer in 2020; p